CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities
Net income	$ 1,059	$ 1,070
Depreciation and amortization	21	39
Amortization of debt discount and debt issuance costs	1,676	431
Accretion of additional financing obligation costs		142
Loss on debt modification		1,100
Change in fair value of additional financing obligation		(695)
Change in fair value of derivative liabilities	(4,268)	(4,183)
Stock issued in lieu of cash	13
Stock based compensation	240	184
Change in assets and liabilities
Accounts receivable, net	(65)	247
Inventory, net	(18)	198
Other assets	(18)	(9)
Accounts payable	(57)	214
Accrued expenses	261	358
Deferred revenue	399	(332)
Billings in excess of costs and estimated earnings on uncompleted contracts	(241)	161
Pension obligation	30	12
Total adjustments	(2,027)	(2,115)
Net cash used in operating activities	(968)	(1,045)
Cash flows from investing activities
Purchase of property and equipment	(8)	(17)
Net cash used in investing activities	(8)	(17)
Cash flows from financing activities
Proceeds from exercised stock options	4
Proceeds from exercised stock purchase warrants	655	500
Proceeds from issuance of notes payable	500	250
Net cash provided by financing activities	1,159	750
Effect of exchange rate changes on cash	(19)	(30)
Net increase (decrease) in cash and cash equivalents	164	(342)
Cash and cash equivalents at beginning of period	103	342
Cash and cash equivalents at end of period	267
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Summary of non-cash investing and financing activities:
Warrants issued with notes payable	188
Additional financing obligation issued with notes payable		140
Non-cash fees added to secured note payable		85
Beneficial conversion feature of convertible debt	188
Conversion of preferred stock into common stock		27
Issuance of common stock pursuant to cashless warrant exercises	$ 12	$ 5